- call +1-201-465-4211
- email sales@mrinsights.biz
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
Scope of the Report:
This report studies the Inflammatory Bowel Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Inflammatory Bowel Disease market by product type and applications/end industries.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
The global Inflammatory Bowel Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Inflammatory Bowel Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Crohns disease
Ulcerative colitis
Market Segment by Applications, can be divided into
Therapeutic
Diagnostics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Inflammatory Bowel Disease Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease
1.2 Classification of Inflammatory Bowel Disease by Types
1.2.1 Global Inflammatory Bowel Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Inflammatory Bowel Disease Revenue Market Share by Types in 2017
1.2.3 Crohns disease
1.2.4 Ulcerative colitis
1.3 Global Inflammatory Bowel Disease Market by Application
1.3.1 Global Inflammatory Bowel Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Therapeutic
1.3.3 Diagnostics
1.4 Global Inflammatory Bowel Disease Market by Regions
1.4.1 Global Inflammatory Bowel Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Inflammatory Bowel Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Inflammatory Bowel Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Inflammatory Bowel Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Inflammatory Bowel Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Inflammatory Bowel Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Inflammatory Bowel Disease (2013-2023)
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb Company
2.1.1 Business Overview
2.1.2 Inflammatory Bowel Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter International
2.2.1 Business Overview
2.2.2 Inflammatory Bowel Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter International Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Inflammatory Bowel Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi-Aventis
2.4.1 Business Overview
2.4.2 Inflammatory Bowel Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi-Aventis Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Inflammatory Bowel Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pluristem Therapeutics
2.6.1 Business Overview
2.6.2 Inflammatory Bowel Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Inflammatory Bowel Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 AstraZeneca
2.8.1 Business Overview
2.8.2 Inflammatory Bowel Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AstraZeneca Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cephalon
2.9.1 Business Overview
2.9.2 Inflammatory Bowel Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cephalon Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Amgen
2.10.1 Business Overview
2.10.2 Inflammatory Bowel Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Amgen Inflammatory Bowel Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Inflammatory Bowel Disease Market Competition, by Players
3.1 Global Inflammatory Bowel Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Inflammatory Bowel Disease Players Market Share
3.2.2 Top 10 Inflammatory Bowel Disease Players Market Share
3.3 Market Competition Trend
4 Global Inflammatory Bowel Disease Market Size by Regions
4.1 Global Inflammatory Bowel Disease Revenue and Market Share by Regions
4.2 North America Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
4.5 South America Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
5 North America Inflammatory Bowel Disease Revenue by Countries
5.1 North America Inflammatory Bowel Disease Revenue by Countries (2013-2018)
5.2 USA Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
6 Europe Inflammatory Bowel Disease Revenue by Countries
6.1 Europe Inflammatory Bowel Disease Revenue by Countries (2013-2018)
6.2 Germany Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
6.3 UK Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
6.4 France Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Inflammatory Bowel Disease Revenue by Countries
7.1 Asia-Pacific Inflammatory Bowel Disease Revenue by Countries (2013-2018)
7.2 China Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
7.5 India Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
8 South America Inflammatory Bowel Disease Revenue by Countries
8.1 South America Inflammatory Bowel Disease Revenue by Countries (2013-2018)
8.2 Brazil Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Inflammatory Bowel Disease by Countries
9.1 Middle East and Africa Inflammatory Bowel Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
10 Global Inflammatory Bowel Disease Market Segment by Type
10.1 Global Inflammatory Bowel Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Inflammatory Bowel Disease Market Forecast by Type (2018-2023)
10.3 Crohns disease Revenue Growth Rate (2013-2023)
10.4 Ulcerative colitis Revenue Growth Rate (2013-2023)
11 Global Inflammatory Bowel Disease Market Segment by Application
11.1 Global Inflammatory Bowel Disease Revenue Market Share by Application (2013-2018)
11.2 Inflammatory Bowel Disease Market Forecast by Application (2018-2023)
11.3 Therapeutic Revenue Growth (2013-2018)
11.4 Diagnostics Revenue Growth (2013-2018)
12 Global Inflammatory Bowel Disease Market Size Forecast (2018-2023)
12.1 Global Inflammatory Bowel Disease Market Size Forecast (2018-2023)
12.2 Global Inflammatory Bowel Disease Market Forecast by Regions (2018-2023)
12.3 North America Inflammatory Bowel Disease Revenue Market Forecast (2018-2023)
12.4 Europe Inflammatory Bowel Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Inflammatory Bowel Disease Revenue Market Forecast (2018-2023)
12.6 South America Inflammatory Bowel Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Inflammatory Bowel Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Inflammatory Bowel Disease Picture
Table Product Specifications of Inflammatory Bowel Disease
Table Global Inflammatory Bowel Disease and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
